Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncoresponse IncfiledCriticalOncoresponse Inc
Publication of AR119440A1publicationCriticalpatent/AR119440A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
En la presente memoria se dan a conocer anticuerpos y métodos de uso de los mismos. Los anticuerpos que se dan a conocer en la presente memoria se unen a CD163+ sobre las células, como tal sucede con los macrófagos. Dichos anticuerpos pueden utilizarse en métodos de tratamiento, tales como métodos para tratar cáncer.Antibodies and methods of using them are disclosed herein. The antibodies disclosed herein bind to CD163+ on cells, as do macrophages. Said antibodies can be used in methods of treatment, such as methods of treating cancer.
ARP200102032A2019-07-192020-07-20
IMMUNOMODULATOR ANTIBODIES AND METHODS OF USE THEREOF
AR119440A1
(en)